A. ÖZDEMİR Et Al. , "Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells," Pharmaceutical Chemistry Journal , vol.53, no.11, pp.1036-1046, 2020
ÖZDEMİR, A. Et Al. 2020. Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells. Pharmaceutical Chemistry Journal , vol.53, no.11 , 1036-1046.
ÖZDEMİR, A., Thranli, S., ÇALIŞKAN, B., Arka, M., & BANOĞLU, E., (2020). Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells. Pharmaceutical Chemistry Journal , vol.53, no.11, 1036-1046.
ÖZDEMİR, AYSUN Et Al. "Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells," Pharmaceutical Chemistry Journal , vol.53, no.11, 1036-1046, 2020
ÖZDEMİR, AYSUN Et Al. "Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells." Pharmaceutical Chemistry Journal , vol.53, no.11, pp.1036-1046, 2020
ÖZDEMİR, A. Et Al. (2020) . "Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells." Pharmaceutical Chemistry Journal , vol.53, no.11, pp.1036-1046.
@article{article, author={AYSUN ÖZDEMİR Et Al. }, title={Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells}, journal={Pharmaceutical Chemistry Journal}, year=2020, pages={1036-1046} }